Development Level

Tbio 33 | 10,625
Tchem 15 | 1,890
Tclin 5 | 602
Tdark 1 | 7,003

IMPC Term

preweaning lethality, complete... 4 | 633
abnormal retina morphology 2 | 100
increased mean corpuscular hem... 2 | 93
increased mean corpuscular vol... 2 | 91
preweaning lethality, incomple... 2 | 260
thrombocytosis 2 | 23
abnormal coat/hair pigmentatio... 1 | 54
abnormal iris pigmentation 1 | 3
abnormal lumbar vertebrae morp... 1 | 6
abnormal retinal pigmentation 1 | 61
abnormal sleep behavior 1 | 63
decreased body weight 1 | 174
decreased bone mineral density 1 | 126
decreased circulating glycerol... 1 | 19
decreased fasted circulating g... 1 | 49
decreased grip strength 1 | 123
decreased hematocrit 1 | 25
decreased lean body mass 1 | 195
decreased lumbar vertebrae num... 1 | 62
decreased mature B cell number 1 | 25
decreased total body fat amoun... 1 | 186
embryonic lethality prior to t... 1 | 187
enlarged heart 1 | 111
hydrops fetalis 1 | 22
increased circulating bilirubi... 1 | 16
increased circulating chloride... 1 | 43
increased circulating serum al... 1 | 25
increased heart weight 1 | 37
increased lean body mass 1 | 107
increased leukocyte cell numbe... 1 | 37
increased or absent threshold ... 1 | 128
increased sacral vertebrae num... 1 | 62
small heart 1 | 8
small kidney 1 | 10
small liver 1 | 8
small lung 1 | 5
small spleen 1 | 11
small superior vagus ganglion 1 | 20

Disease

osteosarcoma 30 | 7,933
ovarian cancer 27 | 8,484
psoriasis 25 | 6,685
Cancer 23 | 2,346
medulloblastoma, large-cell 22 | 6,234
lung cancer 21 | 4,466
atypical teratoid / rhabdoid tumor 17 | 4,369
glioblastoma 17 | 5,572
non-small cell lung cancer 15 | 2,798
invasive ductal carcinoma 14 | 2,950
malignant mesothelioma 14 | 3,162
lung adenocarcinoma 13 | 2,713
Breast cancer 12 | 3,094
group 3 medulloblastoma 12 | 2,254
intraductal papillary-mucinous neoplasm (IPMN) 12 | 3,289
adult high grade glioma 11 | 2,148
diabetes mellitus 11 | 1,663
ependymoma 11 | 2,514
pancreatic cancer 11 | 2,300
Carcinoma 10 | 2,147
dermatomyositis 10 | 933
primitive neuroectodermal tumor 10 | 3,031
Alzheimer's disease 9 | 644
Pick disease 9 | 1,893
cutaneous lupus erythematosus 9 | 1,056
interstitial cystitis 9 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 9 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 9 | 2,988
pilocytic astrocytoma 9 | 3,086
subependymal giant cell astrocytoma 9 | 2,287
group 4 medulloblastoma 8 | 1,875
juvenile dermatomyositis 8 | 1,189
medulloblastoma 8 | 1,524
oligodendroglioma 8 | 2,849
pediatric high grade glioma 8 | 2,712
astrocytoma 7 | 1,493
cystic fibrosis 7 | 1,665
ductal carcinoma in situ 7 | 1,745
lung carcinoma 7 | 2,844
tuberculosis 7 | 1,557
Multiple myeloma 6 | 1,327
Parkinson's disease 6 | 364
Prostatic Neoplasms 6 | 471
Waldenstrons macroglobulinemia 6 | 765
acute quadriplegic myopathy 6 | 1,157
astrocytic glioma 6 | 2,241
atypical teratoid/rhabdoid tumor 6 | 1,095
breast carcinoma 6 | 1,614
pancreatic ductal adenocarcinoma liver metastasis 6 | 1,795
posterior fossa group A ependymoma 6 | 1,511
primary pancreatic ductal adenocarcinoma 6 | 1,271
spina bifida 6 | 1,064
ulcerative colitis 6 | 2,087
Dementia 5 | 129
Diabetes Mellitus, Experimental 5 | 106
Endometriosis 5 | 535
Mammary Neoplasms 5 | 410
nasopharyngeal carcinoma 5 | 1,056
Atherosclerosis 4 | 275
Heart disease 4 | 279
Hypertension 4 | 287
Hypertensive disease 4 | 193
Kidney disease 4 | 396
Lung disease 4 | 132
Neurodegenerative disease 4 | 383
Rheumatoid Arthritis 4 | 1,160
Stomach Neoplasms 4 | 282
adrenocortical carcinoma 4 | 1,427
posterior fossa group B ependymoma 4 | 1,530
primary Sjogren syndrome 4 | 789
sonic hedgehog group medulloblastoma 4 | 1,482
Atopic dermatitis 3 | 944
Bipolar Disorder 3 | 266
Cardiomegaly 3 | 66
Drug-Induced Liver Injury 3 | 118
Duchenne muscular dystrophy 3 | 602
Hyperglycemia 3 | 120
IGA Glomerulonephritis 3 | 454
Liver carcinoma 3 | 217
Metabolic syndrome X 3 | 155
Myocardial Infarction 3 | 126
Obesity 3 | 616
Osteoporosis 3 | 257
Peripheral Neuropathy 3 | 303
Renal Cell Carcinoma 3 | 199
Reperfusion Injury 3 | 84
Schizophrenia 3 | 501
active Crohn's disease 3 | 918
acute myeloid leukemia 3 | 780
esophageal adenocarcinoma 3 | 737
gastric carcinoma 3 | 832
mucosa-associated lymphoid tissue lymphoma 3 | 480
progressive supranuclear palsy 3 | 674
urothelial carcinoma 3 | 318
Down syndrome 2 | 548
aldosterone-producing adenoma 2 | 664
colon cancer 2 | 1,475
fibroadenoma 2 | 557
pancreatic carcinoma 2 | 567
pituitary cancer 2 | 1,972

Tissue

Cardiovascular System 54 | 17,958
Digestive Tract 54 | 18,473
Endocrine System 54 | 18,512
Female tissues 54 | 18,647
Liver and Pancreas 54 | 18,136
Male tissues 54 | 17,969
Nervous System 54 | 18,561
Skin and soft tissues 54 | 18,115
Urinary Tract 54 | 18,444
Blood and immune system 53 | 17,995
Respiratory system 53 | 17,484

Target Family

Non-IDG 27 | 11,971
Enzyme 10 | 4,146
Kinase 10 | 634
Transcription Factor 3 | 1,400
Epigenetic 2 | 242
Ion Channel 1 | 341
Nuclear Receptor 1 | 48

GO Process

negative regulation of protein... 54 | 54
transcription, DNA-templated 1,779 | 1,779
regulation of transcription, D... 1,170 | 1,170
signal transduction 969 | 969
positive regulation of transcr... 845 | 845
G-protein coupled receptor sig... 666 | 666
negative regulation of transcr... 620 | 620
apoptotic process 506 | 506
positive regulation of transcr... 504 | 504
negative regulation of transcr... 483 | 483
multicellular organism develop... 456 | 456
positive regulation of cell pr... 451 | 451
cell differentiation 442 | 442
negative regulation of apoptot... 440 | 440
innate immune response 410 | 410
cell adhesion 409 | 409
immune response 398 | 398
negative regulation of cell pr... 379 | 379
inflammatory response 371 | 371
viral process 368 | 368
spermatogenesis 365 | 365
cell proliferation 358 | 358
protein transport 356 | 356
intracellular signal transduct... 355 | 355
cell division 330 | 330
regulation of transcription fr... 324 | 324
protein phosphorylation 320 | 320
response to drug 297 | 297
positive regulation of apoptot... 292 | 292
nervous system development 275 | 275
transcription from RNA polymer... 272 | 272
cell surface receptor signalin... 267 | 267
protein ubiquitination 260 | 260
transport 257 | 257
cell-cell signaling 249 | 249
regulation of immune response 247 | 247
positive regulation of gene ex... 242 | 242
mitotic nuclear division 241 | 241
MAPK cascade 238 | 238
chemical synaptic transmission 238 | 238
mRNA splicing, via spliceosome 219 | 219
angiogenesis 218 | 218
small GTPase mediated signal t... 215 | 215
translation 215 | 215
rRNA processing 209 | 209
intracellular protein transpor... 205 | 205
cellular response to DNA damag... 201 | 201
cell cycle 200 | 200
proteasome-mediated ubiquitin-... 200 | 200
proteolysis 199 | 199
visual perception 198 | 198
DNA repair 196 | 196
extracellular matrix organizat... 193 | 193
regulation of apoptotic proces... 190 | 190
brain development 183 | 183
positive regulation of cell mi... 181 | 181
protein polyubiquitination 181 | 181
in utero embryonic development 178 | 178
Fc-epsilon receptor signaling ... 176 | 176
Wnt signaling pathway 175 | 175
ion transmembrane transport 174 | 174
protein homooligomerization 173 | 173
heart development 170 | 170
positive regulation of ERK1 an... 170 | 170
blood coagulation 169 | 169
cell migration 168 | 168
regulation of cell proliferati... 167 | 167
protein autophosphorylation 166 | 166
response to hypoxia 164 | 164
mRNA processing 162 | 162
negative regulation of canonic... 162 | 162
protein folding 162 | 162
T cell receptor signaling path... 161 | 161
response to lipopolysaccharide 161 | 161
defense response to virus 160 | 160
RNA splicing 158 | 158
aging 158 | 158
positive regulation of I-kappa... 158 | 158
axon guidance 157 | 157
homophilic cell adhesion via p... 155 | 155
sensory perception of smell 155 | 155
ER to Golgi vesicle-mediated t... 151 | 151
interferon-gamma-mediated sign... 150 | 150
protein ubiquitination involve... 150 | 150
transcription initiation from ... 150 | 150
ubiquitin-dependent protein ca... 149 | 149
DNA replication 144 | 144
adaptive immune response 139 | 139
cell cycle arrest 139 | 139
receptor-mediated endocytosis 139 | 139
skeletal system development 136 | 136
regulation of cell shape 135 | 135
regulation of small GTPase med... 134 | 134
G2/M transition of mitotic cel... 133 | 133
oxidation-reduction process 133 | 133
positive regulation of cytosol... 133 | 133
protein stabilization 133 | 133
sensory perception of sound 132 | 132
positive regulation of NF-kapp... 131 | 131
antigen processing and present... 130 | 130
type I interferon signaling pa... 130 | 130

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Antileukoproteinase SLPI Tbio Enzyme -2.56514 434.2 290
Transmembrane channel-like protein 8 TMC8 Tbio Ion Channel -1.45295 32.2 147
Golgin subfamily A member 2 GOLGA2 Tbio Non-IDG -1.94177 80.5 168
Zinc finger protein ZFPM1 ZFPM1 Tbio Transcription Factor -2.48522 310.9 77
Inactive serine/threonine-protein kinase TEX14 TEX14 Tbio Kinase -0.93273 10.1 57
Glycogen synthase kinase-3 beta GSK3B Tclin Kinase -2.94349 567.7 767
Ras-related protein Ral-B RALB Tbio Enzyme -1.69182 49.7 204
Nestin NES Tbio Non-IDG -3.33502 2122.7 622
Casein kinase I isoform epsilon CSNK1E Tchem Kinase -1.76876 60.7 272
Dickkopf-related protein 1 DKK1 Tchem Non-IDG -2.70833 552.4 624